8% CONVERTIBLE PROMISSORY NOTE DUE OCTOBER 31, 2018Premier Biomedical Inc • November 26th, 2018 • Biological products, (no disgnostic substances) • New York
THIS 8% CONVERTIBLE PROMISSORY NOTE is a duly authorized and validly issued 8% Convertible Promissory Note of Premier Biomedical, Inc. (the “Company”), having its principal place of business at P.O. Box 25, Jackson Center, PA 16133, designated as its 8% Convertible Note due October 31, 2018 (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).
